menu
    • menu

    Company profile for STI PHARMA

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    STI is a specialty pharmaceutical company focused on the acquisition, development and marketing of high-quality pharmaceutical products with a strategic focus on oncology and injectables.Founded in 2008 by Anup Dam, a seasoned industry executive, STI PHARMA is a privately owned, specialty pharmaceutical company focused on the acquisition, development, licensing and commercialization of generic drugs with a strategic focus on i...
    STI is a specialty pharmaceutical company focused on the acquisition, development and marketing of high-quality pharmaceutical products with a strategic focus on oncology and injectables.Founded in 2008 by Anup Dam, a seasoned industry executive, STI PHARMA is a privately owned, specialty pharmaceutical company focused on the acquisition, development, licensing and commercialization of generic drugs with a strategic focus on injectables. We are committed to developing high quality injectables designed to meet evolving patient needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    STI PHARMAUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    190 N. Milwaukee Street Milwaukee, WI 53202
    Telephone
    Telephone
    855 279 0622
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.stipharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    STI's Generic Isoproterenol Hydrochloride Receives Approval in the U.S.
    STI's Generic Isoproterenol Hydrochloride Receives Approval in the U.S.

    20 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215542

    FDA
    20 Sep 2022
    Share Share
    STI Pharmaceuticals Generic Arsenic Trioxide Receives Approval in US
    STI Pharmaceuticals Generic Arsenic Trioxide Receives Approval in US

    08 May 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209873

    FDA
    08 May 2019
    Share Share
    STI Pharmaceuticals Generic Carmustine Receives Approval in US
    STI Pharmaceuticals Generic Carmustine Receives Approval in US

    05 Apr 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209278

    FDA
    05 Apr 2019
    Share Share
    STI Pharma Receives FDA Warning Letter
    STI Pharma Receives FDA Warning Letter

    21 Nov 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/sti-pharma-receives-warning-letter-1480504815.pdf

    FDA
    21 Nov 2016
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact STI PHARMA and get a quotation

    STI PHARMA is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Cannabidiol bulk with DMF offered by STI PHARMA

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search